These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 2160907)

  • 1. [New aspects of the molecular effect of anti-arrhythmia agents].
    Honerjäger P
    Herz; 1990 Apr; 15(2):70-8. PubMed ID: 2160907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New aspects of the electrophysiologic effect of antiarrhythmic agents].
    Antoni H; Weirich J
    Herz; 1990 Apr; 15(2):61-9. PubMed ID: 2188893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular properties of brain sodium channels: an important target for anticonvulsant drugs.
    Catterall WA
    Adv Neurol; 1999; 79():441-56. PubMed ID: 10514834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-arrhythmic and cardiodepressive effects of anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1988; 77 Suppl 5():113-9. PubMed ID: 2464875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of gating and drug block of sodium channels.
    Catterall WA
    Novartis Found Symp; 2002; 241():206-18; discussion 218-32. PubMed ID: 11771647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of late I and antiarrhythmic drugs in EAD formation and termination in Purkinje fibers.
    Fedida D; Orth PM; Hesketh JC; Ezrin AM
    J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S71-S78. PubMed ID: 16686685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Principles for the classification of anti-arrhythmia agents in cardiac arrhythmias].
    Ravens U
    Z Kardiol; 1992; 81 Suppl 4():119-25. PubMed ID: 1290288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular determinants of drug access to the receptor site for antiarrhythmic drugs in the cardiac Na+ channel.
    Qu Y; Rogers J; Tanada T; Scheuer T; Catterall WA
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11839-43. PubMed ID: 8524860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected mexiletine responses of a mutant cardiac Na+ channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access.
    Sasaki K; Makita N; Sunami A; Sakurada H; Shirai N; Yokoi H; Kimura A; Tohse N; Hiraoka M; Kitabatake A
    Mol Pharmacol; 2004 Aug; 66(2):330-6. PubMed ID: 15266024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of action of neurotoxins acting on the inactivation of voltage-gated sodium channels].
    Benoit E
    C R Seances Soc Biol Fil; 1998; 192(3):409-36. PubMed ID: 9759381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Elementary properties and the interaction of single myocardial Na+ channels with antiarrhythmic drugs].
    Kohlhardt M
    Arzneimittelforschung; 1989 Jan; 39(1A):126-9. PubMed ID: 2541732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open and inactivated sodium channel block by class-I antiarrhythmic drugs.
    Kodama I; Toyama J; Yamada K
    Jpn Heart J; 1986 Nov; 27 Suppl 1():83-9. PubMed ID: 2434686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The pro-arrhythmia effects of anti-arrhythmia agents--theoretical and clinical aspects].
    Steinbeck G
    Z Kardiol; 1992; 81 Suppl 4():139-43. PubMed ID: 1290290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ion channels and arrhythmias].
    Borchard U; Hafner D
    Z Kardiol; 2000; 89 Suppl 3():6-12. PubMed ID: 10810780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vaughan Williams class IV antiarrhythmic drugs].
    Horie M; Washizuka T; Ikeguchi S; Sasayama S
    Nihon Rinsho; 1996 Aug; 54(8):2132-7. PubMed ID: 8810788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the role of lidocaine or phenytoin in tricyclic antidepressant-induced cardiotoxicity?
    Foianini A; Joseph Wiegand T; Benowitz N
    Clin Toxicol (Phila); 2010 May; 48(4):325-30. PubMed ID: 20507243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative dromotropic effects of class I antiarrhythmic drugs in anisotropic ventricular muscle.
    Iida M; Kodama I; Toyama J
    Cardiovasc Res; 1996 Apr; 31(4):640-50. PubMed ID: 8689657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class I anti-arrhythmic drugs: structure and function at the cardiac sodium channel.
    Sheldon RS; Duff HJ; Hill RJ
    Clin Invest Med; 1991 Oct; 14(5):458-65. PubMed ID: 1660368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New aspects of frequency-dependent effect of class 1 anti-arrhythmia drugs. A critical analysis of useful subclassification].
    Weirich J; Antoni H
    Z Kardiol; 1991 Mar; 80(3):177-86. PubMed ID: 2058249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.